Search

Learn about Mary Baylies, a developmental biologist studying muscle biology at the Sloan Kettering Institute.

… Mary Baylies is a developmental biologist studying muscle biology at the Sloan Kettering Institute . Her work is clarifying how muscle cells form and are repaired and what goes wrong in muscle disease. We spoke to her in August 2018 about how she got interested in science and what sparked her particular

Esta información de Lexicomp® le explica lo que debe saber sobre este medicamento, por ejemplo, para qué se usa, cómo tomarlo, sus efectos secundarios y cuándo llamar a su proveedor de cuidados de la salud.

… Esta información de Lexicomp ® le explica lo que debe saber sobre este medicamento, por ejemplo, para qué se usa, cómo tomarlo, sus efectos secundarios y cuándo llamar a su proveedor de cuidados de la salud. ¿Para qué se utiliza este medicamento? Este medicamento se utiliza para tratar la insuficiencia

Этот документ, предоставленный Lexicomp®, содержит всю необходимую информацию о препарате, включая показания, способ применения, побочные эффекты и случаи, при которых необходимо связаться с вашим поставщиком медицинских услуг.

… Этот документ, предоставленный Lexicomp ® , содержит всю необходимую информацию о препарате, включая показания, способ применения, побочные эффекты и случаи, при которых необходимо связаться с вашим поставщиком медицинских услуг. Для чего используется этот лекарственный препарат? Применяется для лечения

The third-annual Crain’s New York Business Notable in Healthcare list celebrates outstanding individuals in the healthcare community within the New York metropolitan area, and honors their professional, civic, and philanthropic achievements.

… Monday, August 10, 2020 Memorial Sloan Kettering (MSK) is proud to announce that Physician-in-Chief and Chief Medical Officer Lisa M. DeAngelis, MD , and Community Outreach Manager Julia Ramirez, MA , are included on the Crain’s New York Business 2020 Notable in Healthcare list. The list celebrates outstanding

… Full Title Phase 2 study of Axitinib + PD-1 blockade in Mucosal Melanoma with Pilot Addition of Stereotactic Body Radiotherapy or Ipilimumab in Select Progressors Purpose The purpose of this study is to assess the safety and effectiveness of treatment with axitinib and nivolumab immunotherapy for people

The discovery of a molecular process that slows down cell division could provide new understanding about how some cancers develop.

… Tuesday, April 8, 2014 Summary The discovery of a molecular process that slows down cell division could provide new understanding about how some cancers develop. This image, generated in the lab of molecular biologist Prasad Jallepalli , shows a human cell nucleus — a membrane-enclosed compartment within

… Berlin C, Lange K, Lekaye HC, Hopland K, Phillips S, Piao J,  Tabar V . Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment. Neuro Oncol. 2020 April 2; 22(8): 1126-1137 PMCID: PMC7594568. Dincer Z, Piao J, Niu L, Ganat Y, Kriks S, Zimmer B, Shi S, Tabar V , Studer

Find out how MSK uses radiation therapy to shrink or kill liver tumor cells.

… Radiation therapy can shrink or kill tumor cells. At Memorial Sloan Kettering, we may recommend this approach if you have a primary liver tumor that can’t be removed with surgery. It can be used alone or in combination with chemotherapy or other treatments. Both image-guided radiation therapy and respiratory

The fellowship is structured to provide a two year experience in research and clinical training. The fellowship is the largest and oldest of its kind in the world.

… VIDEO | 01:45 Training at MSK See what it's like to train at Memorial Sloan Kettering, a world-renowned academic medical center dedicated to patient care, research, and education. Video Details As one of the preeminent cancer care institutions in the world, Memorial Sloan Kettering Cancer Center (MSK

… SK2010-069 Description The Caov-3 cell line is a primary ovarian cancer cell line with epithelial morphology. These cells form tightly packed colonies in adherent culture. All-trans retinoic acid has been shown to suppress the growth of Caov-3 ovarian carcinoma cells in vitro . These cells express the